AFP and hepatocellular carcinoma: The GALAD scoring algorithm, comprising gender, age, AFP-L3, AFP, and DCP, has very good performance for HCC detection in large validation studies, including patients of diverse liver disease etiologies, even for detecting early stage HCC (BCLC 0/A) (Berhane et al., 2016; Best et al., 2019).